Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Pulmonary failure; This is a spontaneous report downloaded from the European Medicines Agency (EMA) EudraVigilance-WEB [regulatory authority number DE-PEI-CADR2021015336]. A 61-years-old male patient received bnt162b2 (COMIRNATY,Batch/Lot Number: EJ6797), intravenous on 06Jan2021 at 0.3 mL, single for COVID-19 immunization. Medical history included ongoing hypertension. The patient''s concomitant medications were not reported. The patient experienced pulmonary failure on 15Jan2021.The patient died on 02Feb2021. It was not reported if an autopsy was performed. Outcome of event was fatal. Sender Comment: mild hypertension / mild symptoms one day after vaccination, increasing deterioration within a week, hospitalization in the intensive care unit, lung failure. According to regulatory authority there is an Inconsistent causal association to immunization for the event Pulmonary failure. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166